Dongsung to distribute Genex’s Oral-Lyn
Published: 2008-09-04 06:13:00
Updated: 2008-09-04 06:13:00
Dongsung Pharm says it has entered into an exclusive licensing and distribution agreement with the U.S. Generex biotechnology corporation for the importation, marketing, distribution and sale of Oral-Lyn, Generex's proprietary oral insulin spray product in Korea.
The terms of a $1.5 million de...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
